Dantrium and haematocrit decreased Patient Reports February 13, 2012

Dantrium Side Effects Report #5136871-3
Dantrium side effect was reported by a Physician from JAPAN on Oct 11, 2006. Female patient, 72 years of age, was diagnosed with neuroleptic malignant syndrome, parkinson's disease  and was treated with Dantrium. After drug was administered, patient experienced the following side effects: acarodermatitis, gastric ulcer haemorrhage, haematocrit decreased, haemoglobin decreased, neuroleptic malignant syndrome, red blood cell count decreased, urinary tract infection . Dantrium dosage: 20 MG TWICE DAILY, IV NOS. During the same period patient was treated with MADOPAR, AMAZOLON, DOPS, PERGOLIDE MESYLATE, SOLDEM, DEXTROSE, SOLDOL E. Patient recovered.

Dantrium Side Effects Report #4603638-1
Dantrium side effect was reported by a Physician from on Feb 21, 2005. Male patient, 39 years of age, was diagnosed with neuroleptic malignant syndrome and was treated with Dantrium. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood lactate dehydrogenase increased, condition aggravated, eosinophil percentage increased, gamma-glutamyltransferase increased, haematocrit decreased, haemoglobin decreased. Dantrium dosage: 100 MG DAILY, IV DRIP. During the same period patient was treated with MIDAZOLAM, PANSPORIN, ZANTAC, FUTHAN, GLUCOSE, KIDMIN, MULTAMIN. Patient was hospitalized. Patient recovered.